Merit Medical Systems Shares Outstanding 2012-2026 | MMSI

Merit Medical Systems shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2025 60
2024 59
2023 58
2022 58
2021 57
2020 55
2019 56
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 60
2025-12-31 60
2025-09-30 60
2025-06-30 61
2025-03-31 61
2024-12-31 59
2024-09-30 60
2024-06-30 59
2024-03-31 59
2023-12-31 58
2023-09-30 58
2023-06-30 58
2023-03-31 58
2022-12-31 58
2022-09-30 58
2022-06-30 58
2022-03-31 58
2021-12-31 57
2021-09-30 58
2021-06-30 57
2021-03-31 57
2020-12-31 55
2020-09-30 56
2020-06-30 55
2020-03-31 55
2019-12-31 56
2019-09-30 55
2019-06-30 57
2019-03-31 56
2018-12-31 54
2018-09-30 55
2018-06-30 52
2018-03-31 52
2017-12-31 50
2017-09-30 52
2017-06-30 51
2017-03-31 46
2016-12-31 45
2016-09-30 45
2016-06-30 45
2016-03-31 45
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 44
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 43
2013-09-30 43
2013-06-30 43
2013-03-31 43
2012-12-31 43
2012-09-30 43
2012-06-30 42
2012-03-31 42
2011-12-31 40
2011-09-30 43
2011-06-30 38
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.072B $1.516B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00